1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow High-grade Squamous Intraepithelial Lesion: new trials by email Literature Review of High-grade Squamous Intraepithelial Lesion trials Research Report on High-grade Squamous Intraepithelial Lesion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells HspE7, placebo, laboratory biomarker analysis - Atypical Squamous Cells of Undetermined Significance, Cervical Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 139 | 2004-09-01 | 2013-06-03 |
| S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix celecoxib, anti-cytokine therapy, antiangiogenesis therapy - Stage 0 Cervical Cancer, High-grade Squamous Intraepithelial Lesion | Phase 2 | Withdrawn | SWOG Cancer Research Network | 2013-11-08 |
Squamous Intraepithelial Lesions (2) · Atypical Squamous Cells of the Cervix (1) · Uterine Cervical Dysplasia (1) · Uterine Cervical Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Morphological and Microscopic Findings (2) · Neoplasms (2) · Pathological Conditions, Signs and Symptoms (2) · Precancerous Conditions (2) · Urogenital Diseases (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2) · Genital Neoplasms, Female (1) · Neoplasms by Site (1) · Urogenital Neoplasms (1) · Uterine Cervical Dysplasia (1)
Biological Therapy (1) · Celecoxib (1) · Chemoprevention (1)
National Cancer Institute (NCI) (1) · SWOG Cancer Research Network (1)
United States (1)
Frank Meyskens (1) · William R. Robinson, MD (1)
U10CA037429 (1)